Stifel Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $170

斯迪富维持麦斯莫医疗(MASI.US)买入评级，维持目标价170美元

moomoo资讯 · 2024/11/06 21:37 · 评级/大行评级

Stifel analyst Rick Wise maintains $Masimo (MASI.US)$ with a buy rating, and maintains the target price at $170.

According to TipRanks data, the analyst has a success rate of 57.9% and a total average return of 4.5% over the past year.

AnalystRecentRatingAutoNews_205777_20241106_5e77bd5b0cd08354f017802838aed2e670c417a8_1730957461852607_mm_en

Furthermore, according to the comprehensive report, the opinions of $Masimo (MASI.US)$'s main analysts recently are as follows:

The swift action taken by new management and the board to improve the company's profit and loss statement is viewed positively. With the support of robust consumables revenue growth and hospital contracting, it is anticipated that the company will exceed performance expectations in the fourth quarter and continue this trajectory into 2025.
Following the quarterly results, the focus is now on the year 2025, with expectations for at least a 26% operating margin for stand-alone healthcare, marking a 2% increase from prior projections. A strategic update is anticipated in January.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

斯迪富分析师Rick Wise维持$麦斯莫医疗 (MASI.US)$买入评级，维持目标价170美元。

根据TipRanks数据显示，该分析师近一年总胜率为57.9%，总平均回报率为4.5%。

AnalystRecentRatingAutoNews_205777_20241106_5e77bd5b0cd08354f017802838aed2e670c417a8_1730957461852607_mm_sc

此外，综合报道，$麦斯莫医疗 (MASI.US)$近期主要分析师观点如下：

新管理层和董事会为改善公司的损益表而迅速采取的行动受到积极评价。在强劲的消耗品收入增长和医院合同的支持下，预计该公司将在第四季度超出业绩预期，并将这一轨迹延续到2025年。
根据季度业绩，现在的重点是2025年，预计独立医疗保健的营业利润率至少为26％，较先前的预测增长2％。预计将在一月份发布战略更新。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Stifel Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $170

Stifel Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $170

风险及免责提示

声明